0001127602-17-031223.txt : 20171103
0001127602-17-031223.hdr.sgml : 20171103
20171103171357
ACCESSION NUMBER: 0001127602-17-031223
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171101
FILED AS OF DATE: 20171103
DATE AS OF CHANGE: 20171103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LANDINE MICHAEL J
CENTRAL INDEX KEY: 0001235600
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35299
FILM NUMBER: 171177433
MAIL ADDRESS:
STREET 1: 88 SIDNEY ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 021394136
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alkermes plc.
CENTRAL INDEX KEY: 0001520262
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981007018
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CONNAUGHT HOUSE
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN 4
STATE: L2
ZIP: 00000
BUSINESS PHONE: 00-353-1-772-8000
MAIL ADDRESS:
STREET 1: CONNAUGHT HOUSE
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN 4
STATE: L2
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC
DATE OF NAME CHANGE: 20110804
FORMER COMPANY:
FORMER CONFORMED NAME: Antler Science Two Ltd
DATE OF NAME CHANGE: 20110509
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2017-11-01
0001520262
Alkermes plc.
ALKS
0001235600
LANDINE MICHAEL J
852 WINTER ST.
WALTHAM
MA
02451
1
SVP, Corp Dev., Alkermes, Inc.
Ordinary Shares
2017-11-01
4
M
0
15000
14.13
A
178693
D
Ordinary Shares
2017-11-01
4
S
0
15000
48.7125
D
163693
D
Employee Stock Option (Right to Buy)
14.13
2017-11-01
4
M
0
15000
0
D
2017-11-05
Ordinary Shares
15000
0
D
This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/6/15.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/6/15.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.49 to $49.01. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
These options are fully vested in accordance with their terms.
/s/ Jennifer Baptiste, attorney-in-fact for Michael J. Landine
2017-11-03